lenvatinib and cabozantinib in renal cell carcinoma
Published 8 years ago • 1.8K plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
4:27
lenvatinib in renal cell carcinoma
-
7:17
cabozantinib in renal cell carcinoma
-
4:28
metastatic renal cell carcinoma: lenvatinib phase ii data
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
8:07
tki/io comparison: lenvatinib/pembrolizumab vs cabozantinib/nivolumab vs axitinib/pembrolizumab
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
2:28
the role of cabozantinib in renal cell carcinoma
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
6:42
the role of lenvatinib in advanced rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
1:14
dr. larkin on lenvatinib plus everolimus in patients with rcc
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
6:44
novel agents in development for renal cell carcinoma
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma